doi: 10.1016/0014-2964(77)90017-2.
Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy
- PMID: 923614
- DOI: 10.1016/0014-2964(77)90017-2
Item in Clipboard
Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy
Eur J Cancer (1965).
1977 Oct.
No abstract available
Similar articles
-
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.Br J Cancer. 1976 Aug;34(2):174-9. doi: 10.1038/bjc.1976.140. Br J Cancer. 1976. PMID: 962994 Free PMC article. Clinical Trial.
-
Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.Surg Gynecol Obstet. 1978 Feb;146(2):230-2. Surg Gynecol Obstet. 1978. PMID: 622668
-
Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.Recent Results Cancer Res. 1978;68:375-9. doi: 10.1007/978-3-642-81332-0_56. Recent Results Cancer Res. 1978. PMID: 752873 No abstract available.
-
The role of immunotherapy in the management of patients with malignant melanoma.World J Surg. 1979 Jul 30;3(3):309-20. doi: 10.1007/BF01556582. World J Surg. 1979. PMID: 382645 Review. No abstract available.
-
Immunotherapy of malignant melanoma.J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):559-62. doi: 10.1016/s0190-9622(82)80382-4. J Am Acad Dermatol. 1982. PMID: 6176602 Review. No abstract available.
Cited by
-
Chemotherapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584. World J Surg. 1979. PMID: 382646 Review. No abstract available.
-
Cancer immunotherapy.Can Med Assoc J. 1979 Feb 3;120(3):322-4, 329. Can Med Assoc J. 1979. PMID: 371776 Free PMC article. Review.
-
Combined modality therapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586. World J Surg. 1979. PMID: 382647 Review. No abstract available.
-
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.Br J Cancer. 1978 Apr;37(4):491-6. doi: 10.1038/bjc.1978.76. Br J Cancer. 1978. PMID: 646922 Free PMC article.